Cargando…

Future Impact of Various Interventions on the Burden of COPD in Canada: A Dynamic Population Model

BACKGROUND: Chronic obstructive pulmonary disease (COPD) is a growing economic burden worldwide. Smoking cessation is thought to be the single most effective way of reducing the economic burden of COPD. The impact of other strategies such as interventions that predict risk of disease, reduce progres...

Descripción completa

Detalles Bibliográficos
Autores principales:	Najafzadeh, Mehdi, Marra, Carlo A., Lynd, Larry D., Sadatsafavi, Mohsen, FitzGerald, J. Mark, McManus, Bruce, Sin, Don
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3469627/ https://www.ncbi.nlm.nih.gov/pubmed/23071626 http://dx.doi.org/10.1371/journal.pone.0046746

Ejemplares similares

Gender modifies the effect of body mass index on lung function decline in mild-to-moderate COPD patients: a pooled analysis
por: Chen, Wenjia, et al.
Publicado: (2021)

Trends in Asthma-Related Direct Medical Costs from 2002 to 2007 in British Columbia, Canada: A Population Based-Cohort Study
por: Bedouch, Pierrick, et al.
Publicado: (2012)

Correction: Trends in Asthma-Related Direct Medical Costs from 2002 to 2007 in British Columbia, Canada: A Population Based-Cohort Study
por: Bedouch, Pierrick, et al.
Publicado: (2013)

Post-hospital syndrome in adults with asthma: a case-crossover study
por: Sadatsafavi, Mohsen, et al.
Publicado: (2013)

Predictors of inappropriate and excessive use of reliever medications in asthma: a 16-year population-based study
por: Tavakoli, Hamid, et al.
Publicado: (2018)

Heterogeneity's ruses: the neglected role of between-individual variability in longitudinal studies of COPD exacerbations
por: Sadatsafavi, Mohsen, et al.
Publicado: (2014)

Should the number of acute exacerbations in the previous year be used to guide treatments in COPD?
por: Sadatsafavi, Mohsen, et al.
Publicado: (2021)

Statin use and lung cancer risk in chronic obstructive pulmonary disease patients: a population-based cohort study
por: Raymakers, AJN, et al.
Publicado: (2020)

Trends in hospital admissions for chronic obstructive pulmonary disease over 16 years in Canada
por: Amegadzie, Joseph E., et al.
Publicado: (2023)

Economic burden of asthma: a systematic review
por: Bahadori, Katayoun, et al.
Publicado: (2009)

Extent, trends, and determinants of controller/reliever balance in mild asthma: a 14-year population-based study
por: Khakban, Amir, et al.
Publicado: (2019)

Trends in prescriptions and costs of inhaled medications in chronic obstructive pulmonary disease: a 19-year population-based study from Canada
por: Tavakoli, Hamid, et al.
Publicado: (2019)

Complementary and alternative asthma treatments and their association with asthma control: a population-based study
por: Chen, Wenjia, et al.
Publicado: (2013)

Trends in oral corticosteroids use in severe asthma: a 14-year population-based study
por: Sadatsafavi, Mohsen, et al.
Publicado: (2021)

Benefit–harm analysis of azithromycin for the prevention of acute exacerbations of chronic obstructive pulmonary disease
por: Ahmadian, Safa, et al.
Publicado: (2022)

Antibiotic consumption in children prior to diagnosis of asthma
por: Marra, Fawziah, et al.
Publicado: (2011)

Empowering pharmacists in asthma management through interactive SMS (EmPhAsIS): study protocol for a randomized controlled trial
por: De Vera, Mary A, et al.
Publicado: (2014)

Cost-Effectiveness of Bronchial Thermoplasty, Omalizumab, and Standard Therapy for Moderate-to-Severe Allergic Asthma
por: Zafari, Zafar, et al.
Publicado: (2016)

Direct costs of overdiagnosed asthma: a longitudinal, population-based cohort study in British Columbia, Canada
por: Ng, Bryan, et al.
Publicado: (2019)

Phenotyping COPD exacerbations using imaging and blood-based biomarkers
por: Alotaibi, Nawaf M, et al.
Publicado: (2018)

Phenotyping and outcomes of hospitalized COPD patients using rapid molecular diagnostics on sputum samples
por: Alotaibi, Nawaf M, et al.
Publicado: (2019)

The diagnostic performance of patient symptoms in screening for COPD
por: Johnson, Kate M., et al.
Publicado: (2018)

Pharmacists’ Satisfaction with Work and Working Conditions in New Zealand—An Updated Survey and a Comparison to Canada
por: Lam, Sharon Jessie, et al.
Publicado: (2023)

The Long-Term Burden of COPD Exacerbations During Maintenance Therapy and Lung Function Decline
por: Kerkhof, Marjan, et al.
Publicado: (2020)

Cost-effectiveness of tiotropium versus omalizumab for uncontrolled allergic asthma in US
por: Zafari, Zafar, et al.
Publicado: (2018)

C-reactive protein and N-terminal prohormone brain natriuretic peptide as biomarkers in acute exacerbations of COPD leading to hospitalizations
por: Chen, Yu-wei Roy, et al.
Publicado: (2017)

The association between previous and future severe exacerbations of chronic obstructive pulmonary disease: Updating the literature using robust statistical methodology
por: Sadatsafavi, Mohsen, et al.
Publicado: (2018)

Increasing incidence associated with herpes zoster infection in British Columbia, Canada
por: Marra, Fawziah, et al.
Publicado: (2016)

Genomic testing to determine drug response: measuring preferences of the public and patients using Discrete Choice Experiment (DCE)
por: Najafzadeh, Mehdi, et al.
Publicado: (2013)

The cost-effectiveness of as-needed budesonide-formoterol versus low-dose inhaled corticosteroid maintenance therapy in patients with mild asthma in Canada
por: Sadatsafavi, Mohsen, et al.
Publicado: (2021)

Heterogeneity in the respiratory symptoms of patients with mild-to-moderate COPD
por: Johnson, Kate M, et al.
Publicado: (2018)

A parametric model to jointly characterize rate, duration, and severity of exacerbations in episodic diseases
por: Safari, Abdollah, et al.
Publicado: (2023)

Burden of non-adherence to latent tuberculosis infection drug therapy and the potential cost-effectiveness of adherence interventions in Canada: a simulation study
por: Patel, Anik R, et al.
Publicado: (2017)

Effect of short-term oral prednisone therapy on blood gene expression: a randomised controlled clinical trial
por: Takiguchi, Hiroto, et al.
Publicado: (2019)

ACCEPT 2·0: Recalibrating and externally validating the Acute COPD exacerbation prediction tool (ACCEPT)
por: Safari, Abdollah, et al.
Publicado: (2022)

COPD Exacerbation Biomarkers Validated Using Multiple Reaction Monitoring Mass Spectrometry
por: Leung, Janice M., et al.
Publicado: (2016)

A personalized biomedical risk assessment infographic for people who smoke with COPD: a qualitative study
por: Gupta, Samir, et al.
Publicado: (2022)

Beta-blocker use and COPD mortality: a systematic review and meta-analysis
por: Etminan, Mahyar, et al.
Publicado: (2012)

Enumerateblood – an R package to estimate the cellular composition of whole blood from Affymetrix Gene ST gene expression profiles
por: Shannon, Casey P., et al.
Publicado: (2017)

Impact of a COPD comprehensive case management program on hospital length of stay and readmission rates
por: Alshabanat, Abdulmajeed, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_6d8tjqv0k2k13km1n0crng5l5h